Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) Sees Significant Decrease in Short Interest

Defiance Daily Target 2X Long LMND ETF (NASDAQ:LMNX) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totaling 13,175 shares, a drop of 75.1% from the April 30th total of 52,840 shares. Approximately 4.0% of the company’s shares are sold short. Based on an average daily volume of 28,873 shares, the short-interest ratio is presently 0.5 days.

Defiance Daily Target 2X Long LMND ETF Trading Down 1.1%

LMNX traded down $0.15 during mid-day trading on Friday, hitting $13.74. The stock had a trading volume of 55,596 shares, compared to its average volume of 45,458. Defiance Daily Target 2X Long LMND ETF has a 1-year low of $10.81 and a 1-year high of $55.00. The company has a debt-to-equity ratio of 0.52, a current ratio of 8.37 and a quick ratio of 6.08. The stock’s fifty day simple moving average is $16.21 and its 200-day simple moving average is $25.72. The firm has a market capitalization of $4.53 million, a price-to-earnings ratio of 26.94 and a beta of -12.97.

Defiance Daily Target 2X Long LMND ETF Company Profile

Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; and TDAS, an analysis program designed for development and optimization of nucleic acid assays.